Phoenix Molecular Designs Announces Collaboration To Develop Diagnostic for Triple-Negative Breast Cancer Read more
FDA approves first generic version of Sabril to help treat seizures in adults and pediatric patients with epilepsy Read more
Tom Parke to lead a workshop on the new FDA draft guidance on Adaptive designs during the 11th Annual Conference Read more